Cargando…
Getting the guts to expand stroke treatment: The potential for microbiome targeted therapies
AIMS: This review focuses on the recent literature regarding the role of the gut‐brain axis (GBA) following ischemic stroke. DISCUSSION: Stroke is the 5th leading cause of death and disability in the United States; however, few therapies have been developed to improve prognoses. There is a plethora...
Autores principales: | Monsour, Molly, Croci, Davide M., Agazzi, Siviero, Borlongan, Cesario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314103/ https://www.ncbi.nlm.nih.gov/pubmed/36217699 http://dx.doi.org/10.1111/cns.13988 |
Ejemplares similares
-
Contemplating IL‐6, a double‐edged sword cytokine: Which side to use for stroke pathology?
por: Monsour, Molly, et al.
Publicado: (2022) -
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
por: Gordon, Jonah, et al.
Publicado: (2022) -
Patching Up the Permeability: The Role of Stem Cells in Lessening Neurovascular Damage in Amyotrophic Lateral Sclerosis
por: Monsour, Molly, et al.
Publicado: (2022) -
Mitochondria in Cell-Based Therapy for Stroke
por: Monsour, Molly, et al.
Publicado: (2023) -
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022)